Seroprevalence of hepatitis D virus in Bulgarian outpatients with history of liver dysfunction.

ABSTRACT

The aim of this research was to define the prevalence of antibodies against hepatitis D virus (anti-HDV Ab) in a group of 26 outpatients with liver dysfunction in northeastern Bulgaria. Serum samples were obtained from April 2022 to December 2023 in the "Status" Medical Diagnostic Laboratory, Varna, Bulgaria. We found seroprevalence of anti-HDV Ab in 15.4% (CI 4.3-34.8%) of the target population. Age and gender had no significant role in HDV seropositivity.